Samuel N. Hazen, CEO at HCA Healthcare, Inc. (HCA), sold 86,799 shares at $502.95 ($43.5M) on 2026-02-03, disclosed to the SEC on 2026-02-05.
Seasonal sale ($43.5M) by CEO — this insider has traded HCA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $497.18 | 120 | $60K | 0.1% |
| 2 | $497.18 | 120 | $60K | 0.1% |
| 3 | $498.12 | 4,293 | $2.1M | 4.9% |
| 4 | $498.12 | 4,293 | $2.1M | 4.9% |
| 5 | $498.80 | 5,162 | $2.6M | 5.9% |
| 6 | $498.80 | 5,162 |
| $2.6M |
| 5.9% |
| 7 | $500.02 | 6,189 | $3.1M | 7.1% |
| 8 | $500.02 | 6,189 | $3.1M | 7.1% |
| 9 | $500.69 | 7,395 | $3.7M | 8.5% |
| 10 | $500.69 | 7,395 | $3.7M | 8.5% |
| 11 | $502.15 | 5,002 | $2.5M | 5.8% |
| 12 | $502.15 | 5,002 | $2.5M | 5.8% |
| 13 | $502.95 | 14,716 | $7.4M | 17.0% |
| 14 | $502.95 | 14,716 | $7.4M | 17.0% |
| 15 | $498.35 | 1,045 | $521K | 1.2% |
| Total | $501.01 avg | 86,799 | $43.5M | 100% |
| Filing → |
| HCA | SELL | 2018-02-02 | $5.6M | — | Filing → |
| HCA | SELL | 2015-04-17 | $14.4M | — | Filing → |
| HCA | SELL | 2014-12-29 | $13.5M | — | Filing → |